CAREN ARNETTE: Open Payments
NPI 1912163064 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 77 payments from 26 companies in 2025. Trend: 2023 $1,407 · 2024 $1,508 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $159 |
| Corcept Therapeutics | 5 | $106 |
| Lilly USA, LLC | 5 | $94 |
| PFIZER INC. | 5 | $94 |
| Merck Sharp & Dohme LLC | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Forte Bio-Pharma LLC | 4 | $66 |
| Amgen Inc. | 4 | $65 |
| Novo Nordisk Inc | 3 | $61 |
Products named: Korlym, VERQUVO, XIFAXAN, TRELEGY ELLIPTA, MOUNJARO, UBRELVY, ELIQUIS, PROLATE.
Industry payments across SC — which companies pay providers there.
